PRESS RELEASE published on 05/08/2024 at 07:30, 2 years ago APONTIS PHARMA starts financial year 2024 with growth in revenue of Single Pill combinations and positive net result – forecast for full-year 2024 confirmed APONTIS PHARMA reports growth in revenue of Single Pill combinations and positive net result in Q1 2024, confirming forecast for full-year 2024. Improved EBITDA and new sales model aims to increase revenue further Revenue Growth Forecast APONTIS PHARMA Single Pill Combinations Q1 2024
BRIEF published on 04/16/2024 at 13:05, 2 years ago EV Nickel Inc. Launches Comprehensive 2024 Exploration Program Sustainable Mining Clean Energy Nickel Exploration Canadian Mining Mineral Finance
BRIEF published on 04/16/2024 at 13:05, 2 years ago EV Nickel Inc. lance un programme d'exploration complet pour 2024 Énergie Propre Exploitation Minière Durable Exploitation Minière Canadienne Exploration Du Nickel Financement Minier
PRESS RELEASE published on 04/16/2024 at 13:00, 2 years ago EV Nickel Announces Fully Funded Exploration Program EV Nickel Inc. announces its 2024 exploration program focusing on its significant Nickel deposits in Timmins, Ontario, following a $5.1M financing. The program includes geophysical surveys, metallurgical test work, and diamond drilling Diamond Drilling 2024 Exploration Program EV Nickel Inc. Nickel Deposits Timmins Ontario
PRESS RELEASE published on 04/15/2024 at 14:01, 2 years ago Original-Research: Apontis Pharma AG (von Montega AG): Kaufen Montega AG stuft Apontis Pharma AG hoch und aktualisiert das Kursziel auf 16,50 EUR aufgrund neuer Vertriebsstrategie und Kooperation mit Novartis. Analyst Tim Kruse empfiehlt Kauf Montega AG APONTIS PHARMA AG Kursziel 16,50 EUR Vertriebsstrategie Kooperation Novartis
BRIEF published on 04/05/2024 at 10:22, 2 years 1 month ago APONTIS PHARMA Secures Five-Year Distribution and Marketing Deal with Novartis for Asthma Medications Pharmaceutical Industry Financial Forecast APONTIS PHARMA Asthma Medications Novartis
BRIEF published on 04/05/2024 at 10:22, 2 years 1 month ago APONTIS PHARMA conclut un accord de distribution et de commercialisation de cinq ans avec Novartis pour des médicaments contre l'asthme Prévisions Financières Industrie Pharmaceutique PHARMA APONTIS Médicaments Contre L'asthme Novartis
PRESS RELEASE published on 04/05/2024 at 10:17, 2 years 1 month ago APONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma medications and raises forecast APONTIS PHARMA partners with Novartis for asthma medications distribution and marketing, raising forecast for 2024 financial year Distribution Agreement APONTIS PHARMA Asthma Medications Novartis Forecast Increase
BRIEF published on 04/05/2024 at 10:15, 2 years 1 month ago APONTIS PHARMA AG Enhances Forecast Following Agreement with Novartis APONTIS PHARMA AG Financial Growth Forecast Upgrade Novartis Agreement Asthma Medications
BRIEF published on 04/05/2024 at 10:15, 2 years 1 month ago APONTIS PHARMA AG améliore ses prévisions suite à un accord avec Novartis Croissance Financière APONTIS PHARMA AG Mise À Niveau Des Prévisions Accord Novartis Médicaments Contre L'asthme
Published on 05/11/2026 at 09:05, 1 hour 38 minutes ago Ameriwest Outlines Multiple Additional Breccia Pipe-Style Targets at Bornite from Historical Soil Sampling and Mapping
Published on 05/11/2026 at 08:05, 2 hours 38 minutes ago Tocvan Accelerates Gran Pilar: 5,000+ Meters Drilled to Date, Historic Workings Discovered on South Block, Pilot Progresses
Published on 05/09/2026 at 01:30, 2 days 9 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/11/2026 at 10:05, 37 minutes ago NOTAPE™ Tapeless & Seamless Zipper Pioneers Full-Lifecycle Green Innovation for Sustainable Manufacturing
Published on 05/11/2026 at 10:05, 37 minutes ago Newton Cinema Makes Cannes Market Debut and Announces Salim Ahamed's Fifth Directorial Feature
Published on 05/11/2026 at 10:05, 37 minutes ago VETRESKA Becomes Official Luxury Pet Accessories Partner of Formula 1 Driver Ollie Bearman
Published on 05/11/2026 at 10:00, 42 minutes ago Original-Research: Antimony Resources Corp. (von GBC AG): BUY
Published on 05/11/2026 at 09:16, 1 hour 26 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 28 avril 2026
Published on 05/07/2026 at 19:15, 3 days 15 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days 15 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 3 days 15 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 3 days 15 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026